# FDA WARNING_LETTER - Cangene BioPharma, LLC - February 18, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/cangene-biopharma-llc/fff7ba55-eeac-4a7b-be09-c1d6e3e6ae1e

> FDA WARNING_LETTER for Cangene BioPharma, LLC on February 18, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Cangene BioPharma, LLC
- Inspection Date: 2022-02-18
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/cangene-biopharma-llc/eb6f4303-a431-47f8-9d5b-76b1715d1258)

## Related Officers

- [Director of Investigations Branch](https://www.globalkeysolutions.net/people/nerizza-guerin/407df995-bd23-4948-82c2-e3bf8a6659b7)
- [Jose Hernandez-Guzman](https://www.globalkeysolutions.net/people/jose-hernandez-guzman/5e522aa9-a613-408f-b360-74c0fe4d8b30)

Company: https://www.globalkeysolutions.net/companies/cangene-biopharma-llc/d685e3d6-8e3c-4950-b2f9-9b3aaea0df9d

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02